Relmada Therapeutics, Inc. RLMD Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s other non-current assets?
- Relmada Therapeutics, Inc. (RLMD) reported other non-current assets of $19.5K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Relmada Therapeutics, Inc.'s other non-current assets decreased by 11.3% year-over-year, from $21.98K to $19.5K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s other non-current assets has grown at a 71.9% compound annual growth rate (CAGR), from $1.3K to $19.5K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.